Stock Earnings

Question 1

What are Sonoma Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Sonoma Pharmaceuticals Inc has a total asset of $13, Net loss of $-3

Question 2

What are the key financial ratios for SNOA?

Accepted Answer

Sonoma Pharmaceuticals Inc's Current ratio is 1.44, has a Net margin is -21.42, sales per share of $11.28.

Question 3

How is Sonoma Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Sonoma Pharmaceuticals Inc largest revenue segment is Human Care, at a revenue of 10,110,000 in the most earnings release.For geography, Europe is the primary market for Sonoma Pharmaceuticals Inc, at a revenue of 4,781,000.

Question 4

Is Sonoma Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Sonoma Pharmaceuticals Inc has a net loss of $-3

Question 5

Does Sonoma Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Sonoma Pharmaceuticals Inc has liability of 9

Question 6

How many outstanding shares for Sonoma Pharmaceuticals Inc?

Accepted Answer

Sonoma Pharmaceuticals Inc has a total outstanding shares of 1.63

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	16	14	12	13	12	18
Revenue Growth (YoY)	23%	17%	-8%	8%	-33%	6%
Cost of Revenue	10	8	7	8	8	11
Gross Profit	6	5	4	4	4	6
Selling, General & Admin	7	7	7	8	9	9
Research & Development	2	1	1	0	0	0
Operating Expenses	9	9	9	9	9	10
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-3	-2	-5	-5	-5	-3
Income Tax Expense	0	0	0	0	0	0
Net Income	-3	-3	-4	-5	-5	-3
Net Income Growth	0%	-25%	-20%	0%	67%	0%
Shares Outstanding (Diluted)	1.64	1.24	0.45	3.39	2.65	2
Shares Change (YoY)	59%	173%	-87%	28%	33%	35%
EPS (Diluted)	-2.11	-2.78	-10.63	-1.52	-1.92	-1.97
EPS Growth	-41%	-74%	600%	-21%	-3%	-12%
Free Cash Flow	-2	0	-2	-6	-4	-3
Free Cash Flow Per Share	-1.21	0	-4.4	-1.76	-1.5	-1.5
Gross Margin	37.5%	35.71%	33.33%	30.76%	33.33%	33.33%
Operating Margin	-18.75%	-21.42%	-33.33%	-30.76%	-41.66%	-16.66%
Profit Margin	-18.75%	-21.42%	-33.33%	-38.46%	-41.66%	-16.66%
Free Cash Flow Margin	-12.5%	0%	-16.66%	-46.15%	-33.33%	-16.66%
EBITDA	-3	-3	-4	-4	-5	-3
EBITDA Margin	-18.75%	-21.42%	-33.33%	-30.76%	-41.66%	-16.66%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-3	-3	-4	-4	-5	-3
EBIT Margin	-18.75%	-21.42%	-33.33%	-30.76%	-41.66%	-16.66%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Sonoma Pharmaceuticals Inc (SNOA) Price

SNOA Stock Price Chart

SNOA Income

Follow-Up Questions